Teva Pharmaceutical Industries Limited American Depositary Shares

TEVA 
(NYSE) 
 
$ 7,940 <%= Resources.Global.txtDown %>
Opdateret 18:10:35
Ændring % -1,24% Fald i aktiekurs
Ændring -0,10 Fald i aktiekurs
Volume 1.146.302
Høj $ 8,090
Lav $ 7,725
Åben $ 8,050
ISIN
Seneste luk $ 8,040
# af aktier 1.091,91M
Markedsværdi 8.669,74M USD
I dag

Teva Pharmaceutical Industries
Markedet er åbent (indtil 22:00) - Forsinket 15 min
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  7,94 -2,3% Fald i aktiekurs 23,9% Stigning i aktiekurs -3,2% Fald i aktiekurs -51,9% Fald i aktiekurs -66,1% Fald i aktiekurs
Powered by TradingView

Nyheder om Teva Pharmaceutical Industries

  • Dansk
  • Engelsk
  • Fondsbørsmeddelelser
20 aug
 
20 aug
 
19 aug
 
19 aug
 
19 aug
 
16 aug
 
16 aug
 
16 aug
 
15 aug
 
13 aug
 

Firmaprofil

Teva Pharmaceutical Industries Ltd is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities, headquartered in Israel. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
17. september 2019 18:26:48
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190829.2 - EUROWEB2 - 2019-09-17 18:26:48 - 2019-09-17 18:26:48 - 1 - Website: OKAY